Intellia Therapeutics Inc buy Lokrim
Start price
28.06.21
/
0%
€94.40
Target price
28.06.22
-
Performance (%)
-48.38%
End price
29.06.22
€48.73
Summary
This prediction ended on 29.06.22 with a price of €48.73. Massive losses of -48.38% were the result for the BUY prediction by Lokrim. Lokrim has a follow-up prediction for Intellia Therapeutics Inc, but this time predicts that Intellia Therapeutics Inc is a Sell. This prediction was marked as speculative and is excluded from Lokrim's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Intellia Therapeutics Inc | -6.699% | -6.699% | -37.471% | -78.838% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% | 65.292% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% | 97.467% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% | 39.755% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% | 61.093% |
According to Lokrim what are the pros and cons of Intellia Therapeutics Inc for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Comments by Lokrim for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Buy Intellia Therapeutics Inc
In the thread Trading Intellia Therapeutics Inc
Die von Lokrim gewählte maximale Laufzeit wurde überschritten
Current prediction by Lokrim for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€6.68
31.03.25
31.03.25
-
31.03.26
31.03.26
16.46%
22:26
22:26
Probably not worthwhile Investment
